Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 30 X users
patent: 1 patent

googleplus: 1 Google+ user

Citations

dimensions_citation: 124 Dimensions

Readers on

mendeley: 122 Mendeley

Summary X Patents Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Melanoma Research, 04 Jul 2018

Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma.

This page shows the most recent Google+ posts that mention this research output.

Click here to find out how to access more activity.